1. Home
  2. SPRY vs TBLA Comparison

SPRY vs TBLA Comparison

Compare SPRY & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$9.98

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.00

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRY
TBLA
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SPRY
TBLA
Price
$9.98
$4.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$35.00
$4.75
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
03-19-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
$142,772,000.00
$1,880,771,000.00
Revenue This Year
N/A
$11.31
Revenue Next Year
$126.72
$5.75
P/E Ratio
N/A
$52.88
Revenue Growth
5459.66
10.96
52 Week Low
$6.66
$2.50
52 Week High
$18.90
$4.65

Technical Indicators

Market Signals
Indicator
SPRY
TBLA
Relative Strength Index (RSI) 44.00 38.05
Support Level $10.01 $4.08
Resistance Level $10.79 $4.35
Average True Range (ATR) 0.68 0.10
MACD -0.16 -0.03
Stochastic Oscillator 7.25 4.11

Price Performance

Historical Comparison
SPRY
TBLA

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

Share on Social Networks: